A share price of Twist Bioscience Corp [TWST] is currently trading at $28.56, up 9.55%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The TWST shares have gain 6.29% over the last week, with a monthly amount drifted -10.27%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Twist Bioscience Corp [NASDAQ: TWST] stock has seen the most recent analyst activity on November 04, 2025, when Stephens initiated its Overweight rating and assigned the stock a price target of $41. Previously, Wolfe Research started tracking the stock with Outperform rating on December 13, 2024, and set its price target to $60. On June 04, 2024, Guggenheim initiated with a Buy rating and assigned a price target of $53 on the stock. Goldman upgraded its rating to a Buy and increased its price target to $45 on January 17, 2024. Berenberg initiated its recommendation with a Buy and recommended $27 as its price target on September 27, 2023. Scotiabank started tracking with a Sector Outperform rating for this stock on January 05, 2023, and assigned it a price target of $33. In a note dated January 03, 2023, Evercore ISI upgraded an Outperform rating on this stock and boosted its target price from $28 to $36.
Twist Bioscience Corp experienced fluctuations in its stock price throughout the past year between $23.30 and $55.33. Currently, Wall Street analysts expect the stock to reach $42.33 within the next 12 months. Twist Bioscience Corp [NASDAQ: TWST] shares were valued at $28.56 at the most recent close of the market. An investor can expect a potential return of 48.21% based on the average TWST price forecast.
Analyzing the TWST fundamentals
Trailing Twelve Months sales for Twist Bioscience Corp [NASDAQ:TWST] were 376.57M which represents 16.88% growth. Gross Profit Margin for this corporation currently stands at 0.51% with Operating Profit Margin at -0.36%, Pretax Profit Margin comes in at -0.2%, and Net Profit Margin reading is -0.21%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.17 and Total Capital is -0.25. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 26.33 points at the first support level, and at 24.11 for the second support level. However, for the 1st resistance point, the stock is sitting at 30.12, and for the 2nd resistance point, it is at 31.69.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Twist Bioscience Corp [NASDAQ:TWST] is 3.64. In addition, the Quick Ratio stands at 3.33 and the Cash Ratio stands at 2.0. Considering the valuation of this stock, the price to sales ratio is 4.64, the price to book ratio is 3.66.
Transactions by insiders
Recent insider trading involved WERNER ROBERT F., Officer, that happened on Nov 21 ’25 when 229.0 shares were purchased. Officer, Leproust Emily M. completed a deal on Nov 21 ’25 to buy 2663.0 shares. Meanwhile, Officer Laponis Adam bought 887.0 shares on Nov 21 ’25.
